Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors

被引:10
|
作者
Zhou, Xuan [1 ]
Zhang, Xueyan [1 ]
Zhong, Tangsheng [1 ]
Zhou, Meng [1 ]
Gao, Lan [2 ,4 ]
Chen, Li [1 ,3 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Changchun, Peoples R China
[3] Jilin Univ, Sch Nursing, 965 Xinjiang St, Changchun 130021, Jilin, Peoples R China
[4] First Hosp Jilin Univ, 71 Xinmin St, Changchun 130031, Jilin, Peoples R China
关键词
breast cancer; chemotherapy-related cognitive impairment; nursing; systematic review; older adults; CHEMOBRAIN; ADULTS; AGE;
D O I
10.1111/jan.15842
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
AimsTo examine the prevalence and associated factors of chemotherapy-related cognitive impairment (CRCI) in older breast cancer survivors (BCS).DesignSystematic review.Data SourcesWe searched EMBASE, PubMed, PsychInfo, CINAHL, Cochrance Library, Web of Science, CNKI and SinoMed, without language restrictions, for studies published from the establishment of the database to September 2022.Review MethodsTwo researchers independently examined the full texts, data extraction and quality assessment, and any discrepancies were resolved through discussion with a third reviewer. Quality of evidence was assessed using the Newcastle-Ottawa Scale and the Agency for Healthcare Research and Quality Scale.ResultsThe seven included studies showed that the estimated prevalence of CRCI in older BCS ranged from 18.6% to 27% on objective neuropsychological tests and from 7.6% to 49% on subjective cognitive assessments. The areas most affected were attention, memory, executive functioning and processing speed. CRCI was associated with 10 factors in six categories, including sociodemographic (e.g. age, education level), physiological (e.g. sleep disorders, fatigue and comorbidities), psychological (e.g. anxiety, depression), treatment modalities (e.g. chemotherapy cycles, chemotherapy regimens), genetic (e.g. APOE2, APOE4) and lifestyle factor (e.g. physical inactivity).ConclusionCRCI is multifactorial and has a relatively high prevalence. However, the results of subjective and objective cognitive examinations were inconsistent, possibly due to variations in tools used to evaluate different definitions of CRCI. Nevertheless, as there are few published studies of older BCS, this conclusion still require verification by well-designed studies in the future.ImpactWe found that the prevalence of CRCI in older adults is relatively high and multifactorial, providing evidence for further health care for this population.No Patient or Public ContributionThere was no patient or public involvement.
引用
收藏
页码:484 / 499
页数:16
相关论文
共 50 条
  • [41] The impact of mindfulness on cancer-related cognitive impairment in breast cancer survivors with cognitive complaints
    Melis, Michelle
    Schroyen, Gwen
    Leenaerts, Nicolas
    Smeets, Ann
    Sunaert, Stefan
    Van der Gucht, Katleen
    Deprez, Sabine
    CANCER, 2023, 129 (07) : 1105 - 1116
  • [42] Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study
    Cerulla, Noemi
    Arcusa, Angels
    Navarro, Jose-Blas
    Garolera, Maite
    Enero, Cristina
    Chico, Gloria
    Fernandez-Morales, Luis
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (01) : 179 - 187
  • [43] Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors
    Charo, Lindsey M.
    Homer, Michael, V
    Natarajan, Loki
    Haunschild, Carolyn
    Chung, Karine
    Mao, Jun J.
    DeMichele, Angela M.
    Su, H. Irene
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (03) : 447 - 452
  • [44] A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog')
    Raffa, R. B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 257 - 259
  • [45] Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study
    Noemí Cerulla
    Àngels Arcusa
    José-Blas Navarro
    Maite Garolera
    Cristina Enero
    Glòria Chico
    Luís Fernández-Morales
    Breast Cancer Research and Treatment, 2017, 164 : 179 - 187
  • [46] The dorsolateral prefrontal cortex is selectively involved in chemotherapy-related cognitive impairment in breast cancer patients with different hormone receptor expression
    Chen, Haijun
    Ding, Ke
    Zhao, Jingjing
    Chao, Herta H.
    Li, Chiang-Shan R.
    Cheng, Huaidong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (08): : 1776 - 1785
  • [47] LONGITUDINAL IMPACT OF YOGA ON CHEMOTHERAPY-RELATED COGNITIVE IMPAIRMENT AND QUALITY OF LIFE IN WOMEN WITH EARLY STAGE BREAST CANCER: A CASE SERIES
    Galantino, Mary Lou
    Greene, Laurie
    Daniels, Laura
    Dooley, Brandon
    Muscatello, Laura
    O'Donnell, Laura
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2012, 8 (02) : 127 - 135
  • [48] Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
    Gibson, Erin M.
    Monje, Michelle
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (06) : 531 - 539
  • [49] Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study
    Schrauwen, Wim
    van de Cavey, Joris
    Vingerhoets, Guy
    Vanheule, Stijn
    van den Broecke, Rudy
    Denys, Hannelore
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2020, 26 (08) : 806 - 814
  • [50] Lifestyle factors associated with cognitive functioning in breast cancer survivors
    Hartman, Sheri J.
    Marinac, Catherine R.
    Natarajan, Loki
    Patterson, Ruth E.
    PSYCHO-ONCOLOGY, 2015, 24 (06) : 669 - 675